DK163996C - 1h-indol-3-yl-holdige 1,3-dimethyl-1h-purin-2,6-dioner, fremgangsmaade til fremstilling af forbindelserne samt farmaceutiske praeparater med indhold deraf - Google Patents

1h-indol-3-yl-holdige 1,3-dimethyl-1h-purin-2,6-dioner, fremgangsmaade til fremstilling af forbindelserne samt farmaceutiske praeparater med indhold deraf

Info

Publication number
DK163996C
DK163996C DK444085A DK444085A DK163996C DK 163996 C DK163996 C DK 163996C DK 444085 A DK444085 A DK 444085A DK 444085 A DK444085 A DK 444085A DK 163996 C DK163996 C DK 163996C
Authority
DK
Denmark
Prior art keywords
compounds
indol
dimethyl
preparing
purin
Prior art date
Application number
DK444085A
Other languages
Danish (da)
English (en)
Other versions
DK163996B (da
DK444085D0 (da
DK444085A (da
Inventor
Ludo Edmond Josephine Kennis
Jan Vandenberk
Jozef Martin Boey
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of DK444085D0 publication Critical patent/DK444085D0/da
Publication of DK444085A publication Critical patent/DK444085A/da
Publication of DK163996B publication Critical patent/DK163996B/da
Application granted granted Critical
Publication of DK163996C publication Critical patent/DK163996C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
DK444085A 1984-10-01 1985-09-30 1h-indol-3-yl-holdige 1,3-dimethyl-1h-purin-2,6-dioner, fremgangsmaade til fremstilling af forbindelserne samt farmaceutiske praeparater med indhold deraf DK163996C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65656184 1984-10-01
US06/656,561 US4548939A (en) 1984-10-01 1984-10-01 1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones

Publications (4)

Publication Number Publication Date
DK444085D0 DK444085D0 (da) 1985-09-30
DK444085A DK444085A (da) 1986-04-02
DK163996B DK163996B (da) 1992-04-27
DK163996C true DK163996C (da) 1992-09-21

Family

ID=24633577

Family Applications (1)

Application Number Title Priority Date Filing Date
DK444085A DK163996C (da) 1984-10-01 1985-09-30 1h-indol-3-yl-holdige 1,3-dimethyl-1h-purin-2,6-dioner, fremgangsmaade til fremstilling af forbindelserne samt farmaceutiske praeparater med indhold deraf

Country Status (17)

Country Link
US (1) US4548939A (de)
EP (1) EP0177087B1 (de)
JP (1) JPH0653742B2 (de)
CN (1) CN1011311B (de)
AT (1) ATE60604T1 (de)
AU (1) AU576386B2 (de)
CA (1) CA1262348A (de)
DE (1) DE3581577D1 (de)
DK (1) DK163996C (de)
ES (1) ES8609324A1 (de)
FI (1) FI83220C (de)
GR (1) GR852375B (de)
IE (1) IE58747B1 (de)
NO (1) NO162069C (de)
NZ (1) NZ213498A (de)
PT (1) PT81229B (de)
ZA (1) ZA857553B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH648559A5 (de) * 1981-07-20 1985-03-29 Siegfried Ag Theophyllinderivate und verfahren zu deren herstellung.
US4742057A (en) * 1985-12-05 1988-05-03 Fujisawa Pharmaceutical Co., Ltd. Antiallergic thiazole compounds
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
DK172696B1 (da) * 1987-08-13 1999-05-31 Glaxo Group Ltd Indolderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende forbindelserne
DK733788A (da) * 1988-01-14 1989-07-15 Fujisawa Pharmaceutical Co Indolylpiperidinderivater og fremgangsmaade til fremstilling deraf
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
DE8817122U1 (de) * 1988-12-22 1993-02-04 Boehringer Ingelheim Kg, 55218 Ingelheim Neue Xanthinderivate mit Adenosinantogenistischer Wirkung
DK292A (da) * 1991-11-29 1992-01-02 Tanisake Kk Middel
DE4414113A1 (de) * 1994-04-22 1995-10-26 Merck Patent Gmbh 3-Indolylpiperidine
CN101801362B (zh) * 2007-06-22 2014-01-22 海德拉生物科学公司 用于治疗病症的方法和组合物
US8318728B2 (en) 2008-05-14 2012-11-27 Hydra Biosciences, Inc. Compounds and compositions for treating chemical warfare agent-induced injuries
WO2009140517A1 (en) 2008-05-14 2009-11-19 Hydra Biosciences, Inc. Compounds and compositions for treating chemical warfare agent-induced injuries

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2322470A1 (de) * 1973-05-04 1974-11-21 Boehringer Sohn Ingelheim Neue indolyl-piperidino-(bzw. 1,2,5,6tetrahydro-pyridyl-)butyrophenone und verfahren zu ihrer herstellung
FR2334358A1 (fr) * 1975-12-12 1977-07-08 Sogeras Nouveaux medicaments derives de l'indole
FR2362628A1 (fr) * 1976-08-26 1978-03-24 Roussel Uclaf Nouveaux derives du piperidyl-indole et leurs sels, procede de preparation et application a titre de medicaments
EP0011399A1 (de) * 1978-11-11 1980-05-28 FISONS plc N-Substituierte Theophylline, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE2922159A1 (de) * 1979-05-31 1980-12-04 Boehringer Mannheim Gmbh Neue xanthin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4342870A (en) * 1980-03-28 1982-08-03 Janssen Pharmaceutica N.V. Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives
US4426383A (en) * 1980-09-04 1984-01-17 Eisai Co., Ltd. Theophylline and theobromine derivatives
US4359468A (en) * 1981-02-25 1982-11-16 Boehringer Ingelheim Ltd. Antiallergic N-[4-(indolyl)-piperidino-alkyl]-benzimidazolones
US4443451A (en) * 1981-07-15 1984-04-17 Janssen Pharmaceutica N.V. Bicyclic pyrimidin-5-one derivatives
CH648559A5 (de) * 1981-07-20 1985-03-29 Siegfried Ag Theophyllinderivate und verfahren zu deren herstellung.

Also Published As

Publication number Publication date
IE852403L (en) 1986-04-01
DK163996B (da) 1992-04-27
DK444085D0 (da) 1985-09-30
GR852375B (de) 1986-01-31
NO853856L (no) 1986-04-02
ES8609324A1 (es) 1986-07-16
EP0177087A2 (de) 1986-04-09
EP0177087B1 (de) 1991-01-30
US4548939A (en) 1985-10-22
ES547447A0 (es) 1986-07-16
PT81229A (en) 1985-11-01
CN1011311B (zh) 1991-01-23
JPS6187681A (ja) 1986-05-06
IE58747B1 (en) 1993-11-03
AU4812485A (en) 1986-04-10
ZA857553B (en) 1987-05-27
FI853763L (fi) 1986-04-02
ATE60604T1 (de) 1991-02-15
CA1262348A (en) 1989-10-17
AU576386B2 (en) 1988-08-25
DE3581577D1 (de) 1991-03-07
NO162069C (no) 1989-11-01
JPH0653742B2 (ja) 1994-07-20
FI83220C (fi) 1991-06-10
NZ213498A (en) 1988-04-29
EP0177087A3 (en) 1986-06-11
DK444085A (da) 1986-04-02
FI83220B (fi) 1991-02-28
CN85105804A (zh) 1986-10-22
PT81229B (pt) 1987-11-30
NO162069B (no) 1989-07-24
FI853763A0 (fi) 1985-09-30

Similar Documents

Publication Publication Date Title
ES8706668A1 (es) Un procedimiento para la preparacion de derivados de piperidina.
HUT71130A (en) Condensed indole derivatives of protein kinase c inhibitor activity, process for preparing them and pharmaceutical compositions containing them
ES8603870A1 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
DE69130412D1 (de) Pyrazolopyridinverbindung und Verfahren zu ihrer Herstellung
PH21554A (en) N-(4-piperidinyl)bicyclic condensed-2-imidazolamine derivatives
MY121908A (en) 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them.
PH25504A (en) Novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides pharmaceutical composition containing said compound, method of use thereof
DE3581577D1 (de) 1h-indol-3-yl enthaltende 1,3-dimethyl-1-h-purine-2,6-dione.
EP0184258A3 (en) Novel derivatives of hydroxy- or amino-substituted (piperidinylalkyl)quinazolines
GB8401093D0 (en) Cephem compounds
HUT53664A (en) Process for producing enzyme inhibiting amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
GR852395B (de)
EP0194579A3 (en) 3-pyridylmethylnaphthyl derivatives, process for their preparation and their use as medicaments
SE8303719L (sv) Eburnan-oximderivat, forfarande for framstellning derav samt farmaceutiska kompositioner innehallande dessa foreningar
YU199985A (en) Process for preparation of n-substituted derivatives of azyridine -2-carboxylic acids
HUT43065A (en) Process for preparing 1-/acyl-amino-methyl/-imidazo/1,2-a/-quinoline derivatives and pharmaceutical compositions containing such compounds
DK34882A (da) Fremgangsmaade til fremstilling af peptidderivater
EP0321967A3 (en) Compounds active on the cardiovascular system

Legal Events

Date Code Title Description
PBP Patent lapsed